VEGF is required for growth and survival in neonatal mice

Development

Volumn 126, Issue 6, 1999, Pages 1149-1159

  Gerber, Hans Peter ^a   Hillan, Kenneth J ^a   Ryan, Anne M ^a   Kowalski, Joe ^a   Keller, Gilbert Andre ^a   Rangell, Linda ^a   Wright, Barbara D ^a   Radtke, Freddy ^b   Aguet, Michel ^b   Ferrara, Napoleone ^a  

^a GENENTECH INC   (United States)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Angiogenesis; Apoptosis; Body growth; Conditional gene targeting; CrelloxP; Endothelium; Mouse; Vascular endothelial growth factor (VEGF); VEGF receptors

Indexed keywords

CHIMERIC PROTEIN; IMMUNOGLOBULIN G; PROTEIN INHIBITOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CELL PROLIFERATION; CELL SURVIVAL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORPUS LUTEUM; DEVELOPMENTAL DISORDER; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE TARGETING; GROWTH DISORDER; HISTOLOGY; KIDNEY FAILURE; LIVER FAILURE; MORTALITY; MOUSE; NEWBORN; NONHUMAN; ORGANOGENESIS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BODY CONSTITUTION; CAPILLARIES; CELL DIVISION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE TARGETING; GENES, ESSENTIAL; HEART DEFECTS, CONGENITAL; IMMUNOGLOBULIN G; INTERFERON-ALPHA; KIDNEY; LIVER; LYMPHOKINES; MICE; MICE, MUTANT STRAINS; MUTAGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0032931234     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J. and Keshet, E. (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1, 1024-028.
2. Augustin, H. G., Braun, K., Telemenakis, I., Modlich, U. and Kuhn, W. (1995). Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am. J. Pathol. 147, 339-351.
3. Baker, J., Liu, J. P., Robertson, E. J. and Efstratiadis, A. (1993). Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73-82.
4. Benjamin, L., Hemo, I. and Keshet, E. (1998). A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591-1598.
5. Benjamin, L. E. and Keshet, E. (1997). Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal Proc. Natl. Acad. Sci. USA 94, 8761-8766.
6. Borgström, P., Bourdon, M. A., Hillan, K. J., Sriramarao, P. and Ferrara, N. (1998). Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 35, 1-10.
7. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G. and Cheresh, D. A. (1994). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
8. Broxmwyer, H. E., Cooper, S., Li, Z. H., Song, H. Y., Kwon, B. S., Warren, R. E., Donner, D. B. (1995). Myeloid progenitor cell regulatory effects of vascular endothelial growth factor. Int. J. Hematol. 62, 203-215.
9. Carmeliet, P. and Collen, D. (1998). Vascular development and disorders: Molecular analysis and pathogenic insights. Kidney Internat. 53, 1519-1549.
10. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W. and Nagy, A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
11. Clapp, C., Martial, J. A., Guzman, R. C., Rentier-Delrue, F. and Weiner, R. I. (1993). The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133, 1292-1299.
12. Davis-Smyth, T., Chen, H., Park, J., Presta, L. G. and Ferrara, N. (1996). The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15, 4919-4927.
13. Enholm, B., Jussila, L., Karkkainen, M. and Alitalo, K. (1998). Vascular endothelial growth factor-C: A growth factor for lymphatic and blood vessel endothelial cells. Trends Cardiovasc. Med. 8, 292-296
14. Esser, S., Wolburg, K., Wolburg, H., Breier, G., Kurzchalia, T. and Risau, W. (1998). Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140, 947-959.
15. Ferrara, N., Carver Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell Braxton, L., Hillan, K. J. and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
16. Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H.-P., Nguyen, T.-N., Peers, D., Chisholm, V., Hillan, K. J. and Schwall, R. H. (1998). Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 4, 336-340.
17. Ferrara, N. and Davis-Smyth, T. (1997). The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4-25.
18. Fong, G. H., Rossant, J., Gertsenstein, M. and Breitman, M. L. (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.
19. Gerber, H. P., Dixit, V. and Ferrara, N. (1998a). Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273, 13313-13316.
20. Gerber, H. P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B., Dixit, V. and Ferrara, N. (1998b). VEGF regulates endothelial cell survival by the Pl3-kinase/Akt Signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem. 273, 30336-30345.
21. Gibson, U. E. M., Heid, C. A. and Williams, P. M. (1996). A novel method for real time quantitative RT-PCR. Genome Res. 6, 995-1001
22. Good, D., Polverini, P., Rastinejad, F., Beau, M., Lemons, R., Frazier, W. and Bouck, N. (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624-6628.
23. Gu, H., Marth, J. D., Orban, P. C., Mossmann, H. and Rajewsky, K. (1994). Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106.
24. Hamilton, W. J, Boyd, J. D. and Mossman, H. W. (1962). Human Embryology. William & Wilkins, Baltimore.
25. Heid, C. A., Stevens, J., Livak, K. J. and Williams, P. M. (1996). Real time quantitative PCR. Genome Res. 6, 986-994.
26. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. and Shibuya, M. (1998). Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad Sci. USA 95, 9349-9354.
27. Hirschi, K. K. and D'Amore, P. A. (1996). Pericytes in the microvasculature. Cardiovasc. Res. 32, 687-698.
28. Hogan, B., Beddington, R., Costantini, F. and Lacy, E. (1994). Manipulating the Mouse Embryo, 2nd edition. New York: Cold Spring Harbor Laboratory Press.
29. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R. M. and Aguet, M. (1993). Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742-1745.
30. Jelkmann, W. (1992). Erythropoietin: structure, control of production and function. Physiol. Rev. 72, 449-489.
31. Katoh, O., Tauchi, H., Kawaishi, K., Kimura, A. and Sarow, Y. (1995). Expression of the vascular endothelial growth factor (VEGF) receptor gene. KDR, in hematopietic cells and inhibitory effects of VEGF on apoptotic cell death caused by ionizing radiations. Cancer Res. 55, 5687-5692.
32. Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H. and Ferrara, N. (1996). Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271, 5638-5646.
33. Kitamoto, Y., Tokunaga, H. and Tomita, K. (1997). Vascular endothelial growth factor is an essential molecule for mouse kidney development. J. Clin. Invest. 99, 2351-2357.
34. Kuhn, R., Schwenk, F., Aguet, M. and Rajewsky, K. (1995). Inducible gene targeting in mice. Science 269, 1427-1429.
35. Monacci, W. T., Merrill, M. J. and Oldfield, E. H. (1993). Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 264, C995-1002.
36. Moore, A., Donahue, C., Bauer, K. D. and Mather, J. P. (1998). Simultaneous measurement of cell cycle and apoptotic cell death. In Methods in Cell Biology (ed. J. P. Mather) ), pp. 266-278. Academic Press.
37. Nehls, V. and Drenckhahn, D. (1993). The versatility of microvascular pericytes: From mesenchyme to smooth muscle? Histochemistry 99, 1-12.
38. O'Reilly, M. O., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R. and Folkman, J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
39. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. and Folkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
40. Patan, S., Haenni, B. and Burri, P. H. (1997). Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM). Microvasc. Res. 53, 33-52.
41. Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., Krummen, L., Winkler, M. and Ferrara, N. (1997). Humanization of an anti-VEGF monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 57, 4593-4599.
42. Quinn, T. P., Peters, K. G., De Vries, C., Ferrara, N. and Williams, L. T. (1993). Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533-7637.
43. Ribelin, W. E. and Cox, J. R. (1965). The Pathology of Laboratory Animals. Springfield: Charles C. Thomas.
44. Risau, W. (1995). Differentiation of endothelium. FASEB J. 9, 926-933.
45. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
46. Roberts, W. G. and Palade, G. E. (1995). Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108, 2369-2379.
47. Sage, E. H., Bassuk, J. A., Vost, J. C., Folkman, M. J. and Lane, T. F. (1995). Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca (2+)-binding EF-hand sequence. J. Cell Biochem. 57, 127-140.
48. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L. and Schuh, A. C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
49. Shalaby, F., Ho, J., Stanford, W. L., Fisher, K. D., Schuh, A. C., Schwartz, L., Bernstein, A. and Rossant, J. (1997). A requirement for flk-1 in primitive and definitive hematopoiesis. Cell 89, 981-990.
50. Vecchi, A., Garlanda, C., Lampugnani, M. G., Resnati, C., Matteucci, C., Stoppacciaro, A., Schnurch, H., Risau, W., Ruco, L., Mantovani, A. and Dejana, E. (1994). Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol. 63, 247-254.
51. West, J. B. (1990). Physiological Basis of Medical Practice. Baltimore: William and Wilkins.
52. Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N. and Jain, R. K. (1996). Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA 93, 14765-14770.